Journal Article

Empirical Antimicrobials for Traveler's Diarrhea

Charles D. Ericsson, Robert Steffen, Javier A. Adachi, Luis Ostrosky-Zeichner, Herbert L. DuPont and Charles D. Ericsson

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 31, issue 4, pages 1079-1083
Published in print October 2000 | ISSN: 1058-4838
Published online October 2000 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/318119
Empirical Antimicrobials for Traveler's Diarrhea

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Over 7 million cases of traveler's diarrhea, defined as the passage of ⩾3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominately caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler's diarrhea.

Journal Article.  3084 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.